BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8893961)

  • 1. Pial synangiosis for treatment of Moyamoya syndrome in children.
    Hannon KE
    AORN J; 1996 Oct; 64(4):540-54; quiz 557-60. PubMed ID: 8893961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pial synangiosis for moyamoya syndrome in children.
    Adelson PD; Scott RM
    Pediatr Neurosurg; 1995; 23(1):26-33. PubMed ID: 7495663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Moyamoya disease in the adult population with pial synangiosis.
    Lin N; Aronson JP; Manjila S; Smith ER; Scott RM
    J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Revascularization for Children with Moyamoya Disease: A New Modification to the Pial Synangiosis.
    Chen C; Wang H; Hou B; Luo L; Guo Y
    World Neurosurg; 2018 Feb; 110():e203-e211. PubMed ID: 29102749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
    Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
    Smith ER; McClain CD; Heeney M; Scott RM
    Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography.
    King JA; Armstrong D; Vachhrajani S; Dirks PB
    J Neurosurg Pediatr; 2010 Feb; 5(2):184-9. PubMed ID: 20121368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiographic changes after pial synangiosis in childhood moyamoya disease.
    Robertson RL; Burrows PE; Barnes PD; Robson CD; Poussaint TY; Scott RM
    AJNR Am J Neuroradiol; 1997 May; 18(5):837-45. PubMed ID: 9159360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pial synangiosis in patients with moyamoya younger than 2 years of age.
    Jackson EM; Lin N; Manjila S; Scott RM; Smith ER
    J Neurosurg Pediatr; 2014 Apr; 13(4):420-5. PubMed ID: 24527861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of bilateral dural arteriovenous fistulae following pial synangiosis for moyamoya syndrome: case report.
    Koduri S; Wilkinson DA; Griauzde JM; Gemmete JJ; Maher CO
    J Neurosurg Pediatr; 2019 Apr; 24(1):9-13. PubMed ID: 30978680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pial synangiosis for moyamoya disease. The Bordeaux experience].
    Jecko V; Penchet G; Champeaux C
    Neurochirurgie; 2016 Aug; 62(4):190-6. PubMed ID: 27113323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Navigation-guided clipping of a de novo aneurysm associated with superficial temporal artery-middle cerebral artery bypass combined with indirect pial synangiosis in a patient with moyamoya disease.
    Aburakawa D; Fujimura M; Niizuma K; Sakata H; Endo H; Tominaga T
    Neurosurg Rev; 2017 Jul; 40(3):517-521. PubMed ID: 28555327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down syndrome and moyamoya: clinical presentation and surgical management.
    See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
    J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
    Jea A; Smith ER; Robertson R; Scott RM
    Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion-weighted magnetic resonance imaging used in assessing hemodynamics following superficial temporal artery-middle cerebral artery bypass in patients with Moyamoya disease.
    Li Z; Zhou P; Xiong Z; Ma Z; Wang S; Bian H; Chen J
    Cerebrovasc Dis; 2013; 35(5):455-60. PubMed ID: 23735877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moyamoya Disease in an 18-Month-Old Female Caucasian Complicated by Cerebral Hyperperfusion Syndrome Following Indirect Revascularization.
    Murchison J; Wilson JM; Ray C; Ginsberg J; Nagy L
    Am J Case Rep; 2017 Oct; 18():1077-1080. PubMed ID: 28989169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occipital pial synangiosis.
    Gross BA; Stone SS; Smith ER
    Acta Neurochir (Wien); 2014 Jul; 156(7):1297-300. PubMed ID: 24595541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of a cerebral pial arteriovenous fistula in a patient with sickle cell disease-related moyamoya syndrome: case report.
    Lo Presti A; Weil AG; Fallah A; Peterson EC; Niazi TN; Bhatia S
    J Neurosurg Pediatr; 2015 Aug; 16(2):207-11. PubMed ID: 26053963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.
    Sakata H; Fujimura M; Mugikura S; Sato K; Tominaga T
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e179-84. PubMed ID: 25957910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.